![](https://etimg.etb2bimg.com/thumb/msid-112136467,imgsize-7054,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/patients-push-back-against-novo-nordisk-move-to-scrap-an-insulin-product.jpg)
Patients push back against Novo Nordisk move to scrap an insulin product
By Maggie Fick and Ahmed Aboulenein London: Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and doctors in a dozen U.S. states told …